BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34606417)

  • 21. 4-Hydroxynonenal activates Src through a non-canonical pathway that involves EGFR/PTP1B.
    Zhang H; Forman HJ
    Free Radic Biol Med; 2015 Dec; 89():701-7. PubMed ID: 26453921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria.
    Hébert Chatelain E; Dupuy JW; Letellier T; Dachary-Prigent J
    Cell Mol Life Sci; 2011 Aug; 68(15):2603-13. PubMed ID: 21063895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.
    Barone I; Giordano C; Malivindi R; Lanzino M; Rizza P; Casaburi I; Bonofiglio D; Catalano S; Andò S
    Endocrinology; 2012 Nov; 153(11):5157-66. PubMed ID: 22962253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphatase.
    Bettaieb A; Liu S; Xi Y; Nagata N; Matsuo K; Matsuo I; Chahed S; Bakke J; Keilhack H; Tiganis T; Haj FG
    J Biol Chem; 2011 Mar; 286(11):9225-35. PubMed ID: 21216966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.
    Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):163-74. PubMed ID: 25395617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
    Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
    Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sepsis-induced brain mitochondrial dysfunction is associated with altered mitochondrial Src and PTP1B levels.
    Lyu J; Zheng G; Chen Z; Wang B; Tao S; Xiang D; Xie M; Huang J; Liu C; Zeng Q
    Brain Res; 2015 Sep; 1620():130-8. PubMed ID: 25998537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ER-bound protein tyrosine phosphatase PTP1B interacts with Src at the plasma membrane/substrate interface.
    Monteleone MC; González Wusener AE; Burdisso JE; Conde C; Cáceres A; Arregui CO
    PLoS One; 2012; 7(6):e38948. PubMed ID: 22701734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.
    Hamel-Côté G; Lapointe F; Gendron D; Rola-Pleszczynski M; Stankova J
    Cell Commun Signal; 2019 Mar; 17(1):21. PubMed ID: 30832675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2.
    Bartolomé RA; Martín-Regalado Á; Pintado-Berninches L; Robles J; Ramírez-González MÁ; Boukich I; Sanchez-Gómez P; Balyasnikova IV; Casal JI
    Cell Death Dis; 2023 Nov; 14(11):742. PubMed ID: 37963919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.
    Suwaki N; Vanhecke E; Atkins KM; Graf M; Swabey K; Huang P; Schraml P; Moch H; Cassidy AM; Brewer D; Al-Lazikani B; Workman P; De-Bono J; Kaye SB; Larkin J; Gore ME; Sawyers CL; Nelson P; Beer TM; Geng H; Gao L; Qian DZ; Alumkal JJ; Thomas G; Thomas GV
    Sci Transl Med; 2011 Jun; 3(85):85ra47. PubMed ID: 21632985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
    Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
    Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated Grb14 is an endogenous inhibitor of retinal protein tyrosine phosphatase 1B, and light-dependent activation of Src phosphorylates Grb14.
    Basavarajappa DK; Gupta VK; Dighe R; Rajala A; Rajala RV
    Mol Cell Biol; 2011 Oct; 31(19):3975-87. PubMed ID: 21791607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein tyrosine phosphatase PTP1B in cell adhesion and migration.
    Arregui CO; González Á; Burdisso JE; González Wusener AE
    Cell Adh Migr; 2013; 7(5):418-23. PubMed ID: 24104540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C.
    Mondol AS; Tonks NK; Kamata T
    Free Radic Biol Med; 2014 Feb; 67():285-91. PubMed ID: 24239742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
    Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
    Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 positively regulates MET phosphorylation through inhibiting PTP1B.
    Lu S; Sun Z; Hu W; Yin S; Zhao C; Hu H
    Cancer Sci; 2021 May; 112(5):1878-1887. PubMed ID: 33583114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGF-activated protein tyrosine phosphatase 1B mediates the phosphorylation and degradation of I-kappa-Balpha coupled to NF-kappa-B activation, thereby controlling dendrite morphology.
    Chacón PJ; Arévalo MA; Tébar AR
    Mol Cell Neurosci; 2010 Apr; 43(4):384-93. PubMed ID: 20123020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.